We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
-14.57%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.28B
AUM Growth
-$525M
Cap. Flow
-$73.7M
Cap. Flow %
-3.24%
Top 10 Hldgs %
24.97%
Holding
2,489
New
246
Increased
163
Reduced
899
Closed
122

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$12.9M
2
AAPL icon
Apple
AAPL
+$4.61M
3
MSFT icon
Microsoft
MSFT
+$3.3M
4
T icon
AT&T
T
+$3.04M
5
CERN
Cerner Corp
CERN
+$1.7M

Sector Composition

Rank Sector Weight
1 Technology 21.39%
2 Healthcare 13.76%
3 Financials 11.85%
4 Consumer Discretionary 9.19%
5 Industrials 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIRD icon
1951
Smartbird Inc
BIRD
$31.2M
$24.3K ﹤0.01%
+309
New +$31.2K
NVRI icon
1952
Enviri
NVRI
$564M
$24.3K ﹤0.01%
3,411
-1,520
-31% -$13.7K
CHUY
1953
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$24.1K ﹤0.01%
1,209
UEIC icon
1954
Universal Electronics
UEIC
$66.6M
$23.9K ﹤0.01%
936
YEXT icon
1955
Yext
YEXT
$613M
$23.9K ﹤0.01%
5,006
-2,113
-30% -$11.7K
CASS icon
1956
Cass Information Systems
CASS
$750M
$23.9K ﹤0.01%
706
SHOE
1957
Shoe Station Group
SHOE
$415M
$23.9K ﹤0.01%
1,104
BFST icon
1958
Business First Bancshares
BFST
$1.05B
$23.8K ﹤0.01%
1,119
COGT icon
1959
Cogent Biosciences
COGT
$6.47B
$23.8K ﹤0.01%
2,639
ANIK icon
1960
Anika Therapeutics
ANIK
$283M
$23.8K ﹤0.01%
1,066
TRNS icon
1961
Transcat
TRNS
$888M
$23.7K ﹤0.01%
417
INBX
1962
DELISTED
Inhibrx, Inc. Common Stock
INBX
$23.6K ﹤0.01%
2,082
OPY icon
1963
Oppenheimer Holdings
OPY
$1.23B
$23.6K ﹤0.01%
715
BZH icon
1964
Beazer Homes USA
BZH
$874M
$23.6K ﹤0.01%
1,955
APEI icon
1965
American Public Education
APEI
$828M
$23.6K ﹤0.01%
1,459
GEF.B icon
1966
Greif Class B
GEF.B
$4.22B
$23.5K ﹤0.01%
377
CGEM icon
1967
Cullinan Oncology
CGEM
$1.26B
$23.5K ﹤0.01%
1,830
KNTE
1968
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$23.4K ﹤0.01%
1,852
IBCP icon
1969
Independent Bank Corp
IBCP
$854M
$23.3K ﹤0.01%
1,210
INBK icon
1970
First Internet Bancorp
INBK
$256M
$23.3K ﹤0.01%
632
RYZ
1971
Ryerson Holding Corp
RYZ
$1.5B
$23.2K ﹤0.01%
1,091
TPC
1972
Tutor Perini Cor
TPC
$4.98B
$23.2K ﹤0.01%
2,645
BOC icon
1973
Boston Omaha
BOC
$431M
$23.2K ﹤0.01%
1,124
LOVE
1974
LoveSac
LOVE
$258M
$23.2K ﹤0.01%
844
CENX icon
1975
Century Aluminum
CENX
$4.59B
$23.2K ﹤0.01%
3,144

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2022 Portfolio in Review

As of Q2 2022, Metropolitan Life Insurance Company (MetLife) held 2,489 positions worth $2.28B, down 19% from $2.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Metropolitan Life Insurance Company (MetLife) withdrew a net $73.7M in Q2 2022, closing 122 positions and reducing 899 holdings. Its most notable exit was Cerner Corp, an estimated $1.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in Keurig Dr Pepper worth $1.56M.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2022 buy was Keurig Dr Pepper: 44,056 shares worth $1.56M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $17.7M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $12.9M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Cerner Corp in Q2 2022, selling an estimated $1.7M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 25% of its $2.28B portfolio in Q2 2022.
  • Metropolitan Life Insurance Company (MetLife) opened 246 new positions and closed 122 in Q2 2022.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 19% quarter-over-quarter to $2.28B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2022, filed 11 Aug 2022.